5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3carboxaldehyde-3-oxime → 5-methyl-6-oxo-5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carbonitrile

HRID 67507ノート

反応式

HRID 67507 の反応式
[CH3:1][N:2]1[C:8](=[O:9])[C:7]2[CH:10]=[CH:11][CH:12]=[CH:13][C:6]=2[N:5]2[CH:14]=[N:15][C:16]([CH:17]=[N:18]O)=[C:4]2[CH2:3]1>C(OC(=O)C)(=O)C>[CH3:1][N:2]1[C:8](=[O:9])[C:7]2[CH:10]=[CH:11][CH:12]=[CH:13][C:6]=2[N:5]2[CH:14]=[N:15][C:16]([C:17]#[N:18])=[C:4]2[CH2:3]1

参加物

3

実験手順

A solution of 4.8 g (18.7 mmol) of 5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxaldehyde-3-oxime in 50 ml of acetic acid anhydride is heated to boiling under reflux for 28 hours. After evaporation of the mixture in vacuo, the residue is taken up in 150 ml of chloroform and washed twice with 30 ml of saturated sodium hydrogen carbonate solution each time and with 30 ml of water. The organic phase is dried over magnesium sulphate and evaporated. After column chromatography on silica gel and recrystallisation from ethyl acetate, there is obtained 5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carbonitrile of melting point 184°-186° C.

後処理

  1. temperatureunder reflux for 28 hours
  2. customAfter evaporation of the mixture in vacuo
  3. washwashed twice with 30 ml of saturated sodium hydrogen carbonate solution each time
  4. dry with materialThe organic phase is dried over magnesium sulphate
  5. customevaporated
  6. customAfter column chromatography on silica gel and recrystallisation from ethyl acetate

出典と根拠

ORDレコード
ord-e1579a5839ba4415ba46fa938d5319c6
出典データセット
uspto-grants-1982_08
特許番号
US04346033

反応ノート

読み込み中…